This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
We are very excited to launch our new website! Please take a few moments to click around and explore...
TEMPE, Ariz. (Sept. 8, 2022) — Marion Lanteri, Ph.D., began this week as Creative Testing Solu...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...